Aytu BioScience Inc: Up on deal for EUA authorized COVID-19 antigen tests
** Shares of pharmaceutical company AYTU.O up 6.4% at 92
cents
** AYTU enters into a purchase agreement with a U.S.
supplier of COVID-19 antigen test that has received emergency
use authorization urn:newsml:reuters.com:*:nFWN2II0Q8
** Co says already received first shipment of orders
** Including session's gains, stock had fallen ~5% this year
(Reporting by Chavi Mehta)
((Chavi.mehta@thomsonreuters.com))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations